Penko Shotekov

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Massimo Filippi, Maria A. Rocca, Elisabetta Pagani et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 113 citations

Life Sciences, Neurology, Neuroscience +17

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis

Patrick Vermersch, Luís Brieva, Robert J. Fox et al. · Neurology Neuroimmunology & Neuroinflammation · 2022 · 67 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Primary spinal melanoma with bilateral papilledema

Gueorgui K. Kounin, K. Romansky, Latchezar Traykov et al. · Clinical Neurology and Neurosurgery · 2004 · 45 citations

Medicine, Oncology, Cutaneous Oncology +9

Efficacy and safety of subcutaneous interferon beta-1a in relapsing–remitting multiple sclerosis: Further outcomes from the IMPROVE study

Nicola De Stefano, Maria Pia Sormani, Bettina Stubinski et al. · Journal of the Neurological Sciences · 2011 · 34 citations

Life Sciences, Neurology, Pharmacotherapy +11